Hypertrophic cardiomyopathy is the most common heart disease in cats and the defining inherited risk of the Maine Coon. The heart muscle thickens, the ventricle stiffens, and the cat compensates silently until either a murmur is heard, a clot forms, or the cat presents in heart failure. For owners, the financial feature is the same as the clinical one: it is invisible for a long time.
Prevalence in the breed
Breed screening programmes using echocardiography have reported HCM in roughly a quarter to a third of Maine Coons examined, with the caveat that screened populations are self-selected. A specific genetic test exists for one mutation (A31P in MYBPC3) but it explains only a minority of cases, so a clear DNA result is not a clear cat.
Age of onset is typically between two and eight years, which means a policy bought at kittenhood can accumulate years of premium before the first abnormal echo — and still be the right decision.
Screening and diagnosis
An echocardiogram by a cardiologist costs $400 to $700 and is the only reliable screening tool. Auscultation alone misses a meaningful share of cases, and NT-proBNP blood testing is a rule-out rather than a diagnosis.
Screening protocols recommend echo at one year, then every one to two years. For a breeding cat the schedule is stricter.
| Item | Typical cost | Notes |
|---|---|---|
| Cardiology echo | $400–$700 | Every 1–2 years for screening |
| Genetic test (A31P) | $60–$120 | Explains only a minority of cases |
| Monthly medication | $40–$130 | From stage B2 onward |
| Thromboembolism episode | $1,500–$4,000 | High recurrence risk |
| NT-proBNP panel | $80–$150 | Rule-out, not diagnosis |
Treatment and complications
Asymptomatic cats may need no medication. Once there is outflow obstruction or congestion, treatment includes a beta-blocker or diltiazem, plus furosemide and clopidogrel for congestive failure and clot prevention. Monthly medication typically runs $40 to $130.
The complication that changes the bill is arterial thromboembolism — a clot that paralyses the hind limbs. Survival to discharge is possible but the episode costs $1,500 to $4,000 and recurrence is common. Many owners face a euthanasia decision instead.
How insurers treat feline HCM
HCM is hereditary and insurers apply hereditary rules. On policies that cover hereditary conditions, a diagnosis after the waiting period is generally claimable. On budget tiers it is excluded, and a pre-policy echo noting “mild septal thickening” makes it pre-existing.
Cats are also subject to age-based new-business limits, commonly eight to ten years, which is precisely the window in which HCM becomes clinically apparent.
- Roughly a quarter to a third of screened Maine Coons show HCM.
- The available DNA test explains only a fraction of cases.
- Echocardiography is the only reliable screening method.
- A clot episode is the cost event that changes everything.
The A31P test is useful but incomplete. Owners who rely on a negative result and skip echocardiography can still face HCM — and an insurer will ask for the echo, not the swab.
Key takeaways
- HCM prevalence in Maine Coons justifies screening and insurance.
- Echo is the diagnostic standard; DNA testing is supplementary.
- Medication costs are modest; clot episodes are not.
- Recorded septal thickening before cover becomes pre-existing.
